FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.
[1] Rose WA 2nd, et al. Virol J. 2009 Nov 10;6:195.